KINTARA THERAPEUTICS INC KTRA 深 滬
已收盤 10-17 16:00:00 美东时间
0.2154
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.2154
- 總市值 1198.93万
- 52周最高 156.80
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 2.835
- 委 比 0.00%
- 總股本 5566.06万
- 歷史最高 190225.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 2.835
- 每 手 1
- 風險率 22.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kymera Therapeutics Announces Proposed Public Offering
Kymera Therapeutics announced a $250 million underwritten public offering of its common stock, with an option for underwriters to purchase up to an additional $37.5 million. Proceeds will be used to advance its pipeline of degrader programs for immunological diseases and general corporate purposes. Morgan Stanley, J.P. Morgan, Jefferies, TD Cowen and Leerink Partners are joint book-running managers. The offering is subject to market conditions an...
06-25 20:05
Kintara stock climbs 10% on TuHURA merger update
Shares of Kintara Therapeutics (NASDAQ:KTRA) climbed 10% Monday after the company announced the record date for contingent value rights, or CVRs, to be issued under its merger agreement with TuHURA Bi...
2024-10-15 01:48
Kintara Therapeutics Reveals Improved Financials, Merger Plans
The latest update is out from Kintara Therapeutics ( ($KTRA) ). Kintara Therape...
2024-10-08 19:28
Kintara Therapeutics 2024 EPS $(0.32) Up From $(9.27) YoY; Cash And Cash Equivalents $4.9M
Recent Corporate Developments As previously disclosed, in April 2024 Kintara entered into a definitive merger agreement (the "Merger Agreement") with TuHURA Biosciences, Inc. ("TuHURA"),
2024-10-08 19:16
Kintara Postpones Stockholder Meeting for Merger Decision
Kintara Therapeutics (KTRA) has released an update. Kintara Therapeutics has po...
2024-09-20 21:37
Kintara Therapeutics: Clinical Trial Resumes Amid Merger Uncertainties
Kintara Therapeutics (KTRA) has provided an update. Kintara Therapeutics and Tu...
2024-08-19 21:27
Kintara Therapeutics Eyes Acquisition Amidst Cautionary Advice
Kintara Therapeutics (KTRA) has shared an update. Kintara Therapeutics and TuHU...
2024-07-08 18:57
Kintara Therapeutics Outlines Progress and Potential Risks
An announcement from Kintara Therapeutics (KTRA) is now available. Kintara Ther...
2024-07-01 21:02
Kintara’s Novel Vaccine Shows Promise in Cancer Trial
Kintara Therapeutics (KTRA) has released an update. Kintara Therapeutics, in co...
2024-06-03 21:13
Kintara Therapeutics GAAP EPS of -$0.05
Kintara Therapeutics press release (NASDAQ:KTRA): Q3 GAAP EPS of -$0.05. As of March 31, 2024, Kintara had cash and cash equivalents of approximately $6.35 million. More on Kintara Therapeutics Kintar...
2024-05-15 21:47
